Dr Richard Shaffer is the Clinical Lead for Radiotherapy and Chair of the Radiotherapy Strategy Group for the Royal Surrey County Hospital and the St Lukes Cancer Alliance. He specialises in using chemotherapy and radiotherapy to treat brain tumours, prostate and bladder cancer, and skin cancer. He also treats patients with intracranial stereotactic radiosurgery. He has extensive experience of using highly technical radiotherapy, including Intensity Modulated Radiation Therapy (IMRT) and image-guided radiotherapy (IGRT).
He is at the forefront of the radiotherapy treatment of early Dupuytren's disease of the hand, Ledderhose disease of the feet (plantar fibromatosis), and plantar fasciitis. He acts as a medical advisor to the British Dupuytrens Society, to NICE, and to the Dupuytren’s Disease Support Group.
He has previously chaired the IMRT-IGRT Radiotherapy Group and the Radiotherapy Technology Development Group. He currently chairs the Network Brain Tumour Working Group. He was a member of the NCRI Brain Tumour Clinical Studies Group (2010 - 2015). He is a trustee of the Fountain Centre, a charity which provides information, support, counselling and complementary therapies for cancer patients and their carers and relatives at St Lukes Cancer Centre.
Dr Shaffer has been involved in a number of research projects including planning studies comparing conventional IMRT with volumetric modulated arc therapy (VMAT) and RapidArc in several disease sites such as prostate, breast, high-grade glioma, and paediatric tumours, and has presented and been published widely in the oncology arena. He currently supervises a clinical fellow who is performing research in both clinical and laboratory settings.
Previous to his role at the Royal Surrey County Hospital, Dr Shaffer completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada. He gained further skills in specialist registrar posts at Charing Cross Hospital, Royal Free Hospital and University College London Hospital.